CSI Market
Sign In | Register

Angiodynamics Inc (ANGO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ANGO Annual Cash Flow →
The quarterly cash flow data below helps track how Angiodynamics Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(May 31 2026)
12 Months 		(Feb 28 2026) (Nov 30 2025) (Aug 31 2025) (May 31 2025)
Operating Activities
Income-36.74
Depreciation & amortization33.46
Amortization of Other Assets10.68
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Long-Lived Assets to be Disposed of14.42
Provision For Loan Losses Expensed0.31
Increase (Decrease) in Inventories-10.05
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation18.36
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized0.00
Tax Benefit From Stock Options Exercised-
Amortization Of Acquired Inventory Basis Step Up-
Deferred Income Tax Related To Operating Activity-
Change In Fair Value Of Contingent Consideration-
Loss On Discontinuance Of Product Offering-
Noncash Or Part Noncash Acquisition Intangible Assets And Business Acquired-
Noncashor Part Noncash Acquisition Value of Contingent Consideration Received-
Non Cash Lease Expense1.20
Transaction Costs For Disposition-
Change In Fair Value Of Contingent Consideration One-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable5.75
Increase (Decrease) in Accounts Payable and Accrued Liabilities-5.83
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.12
Other Working Capital0.00
Other Noncash Income (Expense)-1.97
Other net-0.07
Payments for (Proceeds from) Other Operating Activities-26.36
Discontinued operations0.00
Net Cash flow from Operating Activities3.09
Investing Activities
Capital Expenditures-2.58
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Proceeds From Escrow Receivable-
Payments To Acquire Intangible Assets Net Of Cash Acquired-
Increase In Placement And Evaluation Units-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-3.74
Discontinued operations0.00
Net Cash Flow from Investing Activities-5.95
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.56
Payment Of Contingent Consideration-
Proceeds Outlays Issuance Of Shares Share Based Payment Arrangement Including Option Exercised-
Proceeds Payments Issuance Of Shares Share Based Payment Arrangement Including Option Exercised-
Finance Lease Principal Payments-0.28
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.56
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow0.51
Total Cash Flow-2.03
4 historic quarters locked

Sign in to unlock the full Angiodynamics Inc cash flow history.

Sign In Create Free Account

About Angiodynamics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-023008

Figures are derived from filed reports and may be restated. Historical data is subject to revision.